United States — Food and Drug Administration & Peretz Bronstein

United States — Food and Drug Administration: The United States — Food and Drug Administration issued a Complete Response Letter to Aldeyra Therapeutics, citing a lack of substantial evidence for the efficacy of reproxalap, which triggered the stock price drop and subsequent lawsuits.

Peretz Bronstein: Peretz Bronstein is a founding partner of Bronstein, Gewirtz & Grossman, LLC, actively involved in the class action lawsuit against Aldeyra Therapeutics.

United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs treated with Bedinvetmab, which contributed to weakening prescription growth for Zoetis' product.

Peretz Bronstein: Peretz Bronstein is the Founding Partner of Bronstein, Gewirtz & Grossman, LLC, a firm actively involved in the class action lawsuit against Zoetis.

United States — Food and Drug Administration: The United States — Food and Drug Administration issued a warning letter to ImmunityBio regarding misleading efficacy claims made by Patrick Soon-Shiong about Anktiva, which triggered the stock price drop and subsequent lawsuits.

Peretz Bronstein: Peretz Bronstein is a founding partner of Bronstein, Gewirtz & Grossman, LLC, which has filed a class action lawsuit against ImmunityBio.